 1
West is a global provider of containment and delivery devices for COVID-19 vaccines and therapeutics.
# 2
The company has been investing in digital technology and automation to improve productivity and efficiency at every level of the organization.
# 3
West has been expanding its HVP manufacturing capacity at existing sites to meet anticipated 2021 COVID-19 vaccine demand.
# 4
The company's full-year 2020 net sales guidance is in a range of between $2.1 billion and $2.11 billion, with an estimated organic sales growth of approximately 14% to 15%.
# 5
West has received FDA clearance for its 20 millimeter Vial2Bag advanced product, and the team is excited to bring it to healthcare professionals.
# 6
The company's mission is to keep team members safe and ensure uninterrupted supply of high-quality containment and delivery devices required by customers and patients.
# 7
West's performance in the third quarter was strong, with over 18% organic sales growth and a contract manufacturing third-quarter gross profit margin of 17.9%.
# 8
The company's cash balance at September 30, 2020 was $519.4 million, $80.3 million more than its December 2019 balance, primarily due to positive operating results.
# 9
West has been investing in digital technology and automation to bring new connected products to market and enhance the productivity of its operations at every level.
# 10
The company's team has been agile in bringing forward production capacity expansion to meet customer requirements.
# 11
West has received FDA clearance for its 20 millimeter Vial2Bag advanced product,